Sep 04, 2025
How Inflation Is Impacting Medical Malpractice Claims
Our 2025 study of the impact of inflation on the medical malpractice insurance industry estimates that increasing economic and social inflation added $4 billion in insured losses and expenses incurred by physician-focused insurers. This is a $1.6 billion increase from the previous estimate in our 2023 study. The latest research confirms that inflation is not only persistent—it’s accelerating.
Search
Reduce Clinician Burnout and Improve Well-Being With People-First Leadership
Solving burnout requires a comprehensive organizational commitment and people-first leaders who have the tenacity to change systems and deliver solutions.
October 01, 2025, Cardiology Magazine
Incidental Findings in Cardiac Imaging: Clinical Opportunity or Legal Liability?
Advances in cardiac imaging technology are leading to increased detection of incidental, noncardiac abnormalities within scanned areas. Pulmonary nodules are one of the most common incidental findings. If the ordering practitioner does not follow up, an incidental finding may lead to patient harm and result in a malpractice claim.
Mar 04, 2024
Loss Lessons: Practicing Out of Bounds
Our complimentary on-demand course provides strategies for establishing policies and protocols to address scope of practice for unlicensed staff.
From
The Doctor’s Advocate
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to the pending acquisition of ProAssurance by The Doctors Company.
Professional Education
Module 4: Recognition, Diagnosis, and Treatment of Substance Use Disorder (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will be shown strategies for recognizing substance use disorder (SUD) and opioid use disorder (OUD). Refamiliarize yourself with screening for fentanyl. Provide valuable pharmacological and nonpharmacological resources to connect patients to treatment for addiction. Discuss individualized treatment plans that are tailored to specific patient needs when treating OUD. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Sep 01, 2023
Dental Case Studies
The case studies presented here provide insights into closed claim scenarios that can help dental professionals enhance their practices as they mitigate risks.
Resources for Practice Managers
Get all our expert resources on important practice management topics, including OSHA standards, compliance, training, checklists, and tools.
Jun 18, 2024
Spotlight on Foundation Grants: Using AI to Assess Cataract Surgery Performance
The Doctors Company Foundation highlights a project to develop an AI system for assessing surgical competency in cataract surgery.
From
The Doctor’s Advocate
Nuclear Verdicts in Healthcare: How Social Inflation Impacts Physicians, Patients, and the Future of Medicine
Social inflation increases the price of healthcare. It ratchets up the costs of doing business for healthcare professionals and facilities, and fear of litigation inspires defensive medicine. Fortunately, through tort reform, states may be able to contain social inflation’s effects on healthcare costs.
